Galixir

About:

Galixir is an artificial intelligence technology to promote the research and development of new drugs.

Website: http://www.galixir.com/

Top Investors: Gaorong Capital, Source Code Capital, DCM Ventures, 5Y Capital, Taihill Venture

Description:

Galixir is an artificial intelligence technology to promote the research and development of new drugs. Our artificial intelligence drug discovery platform can help drug research and development scientists greatly save time and cost in drug development. At the same time, our platform also provides comprehensive patent protection coverage for the drugs developed. Relying on cutting-edge artificial intelligence technology, Xingyao combines engineering chemistry, computational chemistry, computational biology, and cloud computing technologies to serve the various processes of drug development.

Total Funding Amount:

$10M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Shenzhen, Guangdong, China

Founded Date:

2019-01-01

Contact Email:

info(AT)galixir.com

Founders:

Chengtao Li

Number of Employees:

101-250

Last Funding Date:

2020-12-29

IPO Status:

Private

© 2024 MyAiNote.com